Marinomed Biotech AG started trading on the prime market, the top segment of the Vienna Stock Exchange on 1 February 2019. The IPO of Marinomed Biotech AG was the first in Europe this year. The start of trading was traditionally celebrated with the bell-ringing ceremony: The Marinomed management board Andreas Grassauer (CEO), Eva Prieschl-Grassauer (CSO) and Pascal Schmidt (CFO) rang the bell together with Vienna Stock Exchange CEO Christoph Boschan.
All Videos at a Glance
150 anniversary Prague Stock Exchange
250 anniversary Vienna Stock Exchange
Vienna Stock Exchange Award 2021
ATX or ATX TR – the dividend makes the difference
Austrian Stock Talk
Future Forum
First trading day of Aventa AG in direct market plus
Vienna Stock Exchange Award 2020
Excellence for debt securities
First trading day of Addiko Bank AG
Delivering a world of good deals
IPO of Frequentis AG
Thinking AUT Loud | The Sound of Finance
IPO of Marinomed Biotech AG
Launch event direct market plus
FESE Convention 2018
direct market plus – Easy access to the capital market
Vienna Stock Exchange Award 2018: The Oscar of the financial community goes to CA Immo
ETF trading at the Vienna Stock Exchange
IPO of BAWAG Group AG
ATX, CECE & Co. – Index know-how of the Vienna Stock Exchange
Vienna Stock Exchange Award 2017: The Oscar of the financial community goes to voestalpine
Stocks and Bonds: Listing on the Vienna Stock Exchange
Going Public: Boost for innovation & growth
